Investigational Site Number : 6430005

Saint Petersburg 197101

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion) — Completed
• Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis — Completed
• Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis — Running, not enrolling
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed